Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I

Canadian Journal of Physiology and Pharmacology

Volumn 84, Issue 11, 2006, Pages 1163-1175

  Greco, A Joel ^a   Master, Ryan G ^a   Fokin Jr , Alex ^a   Baber, Syed R ^a   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

A 779; Angiotensin (1 7); Angiotensin (1 7) receptor; Angiotensin (1 7) receptor antagonist; Angiotensin converting enzyme; Angiotensin converting enzyme inhibitors; Bradykinin; Bradykinin B2 receptors; Cyclooxygenase; Hoe 140; Vascular responses

Indexed keywords

A 779; ACETYLCHOLINE; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN[1-7]; BETA 2 ADRENERGIC RECEPTOR; BRADYKININ; BRADYKININ DERIVATIVE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; ICATIBANT; LOSARTAN; MECLOFENAMATE SODIUM; NITROPRUSSIDE SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; DRUG SENSITIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRADYKININ; CAROTID ARTERY, EXTERNAL; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENALAPRILAT; MALE; MECLOFENAMIC ACID; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B2; RECEPTORS, G-PROTEIN-COUPLED; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 33947514421     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y06-053     Document Type: Article

References (56)

1. Bayorh, M.A., Eatman, D., Walton, M., Socci, R.R., Thierry-Palmer, M., and Emmett, N. 2002. A-779 attenuates angiotensin-(1-7) depressor response in salt-induced hypertensive rats. Peptides, 23: 57-64. doi:10.1016/S0196- 9781(01)00579-4.
2. Britto, R.R., Santos, R.A., Fagundes-Moura, C.R., Khosla, M.C., and Campagnole-Santos, M.J. 1997. Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats. Hypertension, 30: 549-556.
3. Brosnihan, K.B., Li, P., and Ferrario, C.M. 1996. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension, 27: 523-528.
4. Burrell, L.M., Johnston, C.I., Tikellis, C., and Cooper, M.E. 2004. ACE2, a new regulator of the renin-angiotensin system. Trends Endocrinol. Metab. 15: 166-169.
5. Calhoun, D.A., Wei, C.C., Zhu, S., Bradley, W.E., and Dell'Italia, L.J. 2001. Enalaprilat blunts reflexive increases in cardiac interstitial norepinephrine in conscious rats. J. Hypertens. 19: 2025-2029. doi:10.1097/00004872-200111000-00013.
6. Campbell, D.J., Kladis, A., and Duncan, A.M. 1994. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension, 23: 439-449.
7. Carey, R.M., and Siragy, H.M. 2003. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr. Rev. 24: 261-271. doi:10.1210/er.2003-0001.
8. Champion, H.C., and Kadowitz, P.J. 1998. D-[Ala2]endomorphin 2 and endomorphin 2 have nitric oxide-dependent vasodilator activity in rats. Am. J. Physiol. 274: H1690-H1697.
9. Champion, H.C., Santiago, J.A., Czapla, M.A., Bivalacqua, T.J., Ilgenfritz, C., and Kadowitz, P.J. 1997. Comparison of responses to T-kinin and bradykinin in the mesenteric vascular bed of the cat. Peptides, 18: 1357-1364. doi:10.1016/S0196-9781(97)00197-6.
10. Costa, E.A., Luna Filho, B., Povoa, R., Ferreira Filho, C., Murad, N., Ferreira, M., and Ferreira, C. 1997. Enalaprilat in the prevention of left ventricular hypertrophy induced by isoproterenol. Arq. Bras. Cardiol. 69: 35-39.
11. Dabisch, P.A., Kerut, E.K., Liles, J.T., Wien, G., Smith, M., Patterson, M., et al. 2004. Responses to bradykinin are mediated by NO-independent mechanisms in the rat hindlimb vascular bed. Pharmacol. Res. 50: 575-584. doi:10.1016/j.phrs.2004.07.001.
12. Danser, A.H., Tom, B., de Vries, R., and Saxena, P.R. 2000. L-NAME-resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: effect of ACE inhibition. Br. J. Pharmacol. 131: 195-202. doi:10.1038/sj.bjp.0703555.
13. Deddish, P.A., Marcic, B., Jackman, H.L., Wang, H.Z., Skidgel, R.A., and Erdos, E.G. 1998. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE. Hypertension, 31: 912-917.
14. Dendorfer, A., Reibetamann, S., Wolfram, S., Raasch, W., and Dominiak, P. 2001. Potentiation of kinin analogues by ramiprilat is exclusively related to their degradation. Hypertension, 38: 142-146.
15. DeWitt, B.J., Cheng, D.Y., McMahon, T.J., Nossaman, B.D., and Kadowitz, P.J. 1994. Analysis of responses to bradykinin in the pulmonary vascular bed of the cat. Am. J. Physiol. 266: H2256-H2267.
16. Donoghue, M., Wakimoto, H., Maguire, C.T., Acton, S., Hales, P., Stagliano, N., et al. 2003. Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins. J. Mol. Cell. Cardiol. 35: 1043-1053. doi:10.1016/S0022-2828(03)00177-9.
17. 2 receptor selective agonist which is not broken down by either kininase I or kininase II. Eur. J. Pharmacol. 155: 193-195. doi:10.1016/0014-2999(88)90423-2.
18. Erdös, E.G., Jackman, H.L., Brovkovych, V., Tan, F., and Deddish, P.A. 2002. Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin. J. Mol. Cell. Cardiol. 34: 1569-1576. doi:10.1006/jmcc.2002.2080.
19. Eriksson, U., Danilczyk, U., and Penninger, J.M. 2002. Just the beginning: novel functions for angiotensin-converting enzymes. Curr. Biol. 12: R745-R752. doi:10.1016/S0960-9822(02)01255-1.
20. Fernandes, L., Fortes, Z.B., Nigro, D., Tostes, R.C., Santos, R.A., and Catelli De Carvalho, M.H. 2001. Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo. Hypertension, 37: 703-709.
21. Ferrario, C.M., Chappell, M.C., Tallant, A.E., Brosnihan, B.K., and Diz, D.I. 1997. Counterregulatory actions of angiotensin-(1-7). Hypertension, 30: 535-541.
22. Garrison, E.A., and Kadowitz, P.J. 1996. Analysis of responses to angiotensin I-(3-10) in the hindlimb vascular bed of the cat. 270 (4 Pt 2): H1172-7.
23. Gumusel, B., Hao, Q., Hyman, A.L., Kadowitz, P.J., Champion, H.C., Chang, J.K., Mehta, J.L., and Lippton, H. 1998. Analysis of responses to adrenomedullin-(13-52) in the pulmonary vascular bed of rats. Am. J. Physiol. 274: H1255-H1263.
24. Iyer, S.N., Chappell, M.C., Averill, D.B., Diz, D.I., and Ferrario, C.M. 1998. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension, 31: 699-705.
25. Li, P., Chappell, M.C., Ferrario, C.M., and Brosnihan, K.B. 1997. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension, 29: 394-400.
26. Lima, C.V., Paula, R.D., Resende, F.L., Khosla, M.C., and Santos, R.A. 1997. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats. Hypertension, 30: 542-548.
27. Linz, W., Wiemer, G., Gohlke, P., Unger, T., and Scholkens, B.A. 1995. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev. 47: 25-49.
28. Lippton, H.L., Nandiwada, P.A., Hyman, A.L., and Kadowitz, P. 1984. Influence of cyclooxygenase blockade on responses to isoproterenol, bradykinin and nitroglycerin in the feline pulmonary vascular bed. Prostaglandins, 28: 253-270. doi:10.1016/0090-6980(84)90061-3.
29. Machado R.D., Ferreira M.A., Belo A.V., Santos R.A., Andrade S.P. 2002. Vasodilator effect of angiotensin-(1-7) in mature and sponge-induced neovasculature. Regul. Pept. 15;107(1-3):105-13.
30. Maia, L.G., Ramos, M.C., Fernandes, L., de Carvalho, M.H., Campagnole-Santos, M.J., and Souza dos Santos, R.A. 2004. Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats. J. Cardiovasc. Pharmacol. 43: 685-691.
31. 2 receptor. Hypertension, 33: 835-843.
32. Minshall, R.D., Tan, F., Nakamura, F., Rabito, S.F., Becker, R.P., Marcic, B., and Erdös, E.G. 1997. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors: the role of expressed human bradykinin B2 receptors and angiotensin-converting enzyme in CHO cells. Circ. Res. 81: 848-856.
33. Nossaman, B.D., Feng, C.J., Kaye, A.D., and Kadowitz, P.J. 1995. Analysis of responses to ANG IV: effects of PD-123319 and DuP-753 in the pulmonary circulation of the rat. Am. J. Physiol. 268: L302-L308.
34. Nossaman, B.D., Kaye, A.D., Feng, C.J., Kang, B., and Kadowitz, P.J. 1997. Analysis of responses to bradykinin in the rat hindquarters vascular bed. Am. J. Physiol. 272: R631-R639.
35. Oliveira, M.A., Fortes, Z.B., Santos, R.A.S., Kosla, M.C., and De Carvalho, M.H.C. 1999. Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo. Peptides, 20: 1195-1201.
36. Osei, S.Y., Ahima, R.S., Minkes, R.A., Weaver, J.P., Khosla, M.C., Kadowitz, P.J. 1993. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur. J. Pharmacol. 234(1): 35-42. doi:10.1016/0014-2999(93)90703-K.
37. Paula, R.D., Lima, C.V., Britto, R.R., Campagnole-Santos, M.J., Khosla, M.C., and Santos, R.A.S. 1999. Potentiation of the hypotensive effect of bradykinin by angiotensin-(1-7)-related peptides. Peptides, 20: 493-500. doi:10.1016/S0196-9781(99)00031-5.
38. Paula, R.D., Lima, C.V., Khosla, M.C., and Santos, R.A. 1995. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension, 26: 1154-1159.
39. Pham, I., Gonzalez, W., Doucet, J., Fournie-Zaluski, M.C., Roques, B.P., Michel, J.B. 1996 Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: influence of bradykinin. Eur. J. Pharmacol. 296: 267-276.
40. Porsti, I., Bara, A.T., Busse, R., and Hecker, M. 1994. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br. J. Pharmacol. 111: 652-654.
41. Ren, Y., Garvin, J.L., and Carretero, O.A. 2002. 2002. Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension, 39: 799-802. doi:10.1161/hy0302.104673.
42. Roks, A.J., van Geel, P.P., Pinto, Y.M., Buikema, H., Henning, R.H., de Zeeuw, D., and van Gilst, W.H. 1999. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension, 34: 296-301.
43. Sampaio, W.O., Sascimento, A.A.S., and Santos, R.A.S. 2003. Regulation of cardiovascular signaling by kinins and products of similar converting enzyme systems: systemic and regional hemodynamic effects of angiotensin-(1-7) in rats. Am. J. Physiol. Heart Circ. Physiol. 284: H1985-H1994.
44. Santos, R.A.S., Campagnole-Santos, M.J., and Andrade, S.P. 2000. Angiotensin-(1-7): an update. Regul. Pept. 91: 45-62. doi:10.1016/S0167-0115(00)00138-5.
45. Santos, R.A., Campagnole-Santos, M.J., Baracho, N.C., Fontes, M.A., Silva, L.C., Neves, L.A., et al. 1994. Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res. Bull. 35: 293-298. doi:10.1016/0361-9230(94)90104-X.
46. Santos, R.A.S., Simoes e Silva, A.C., Marie, C., Silva, D.M., Machado, R.P., de Buhr, I., et al. 2003. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A. 100: 8258-8263. doi:10.1073/pnas.1432869100.
47. Schmaier, A.H. 2003. The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285: R1-R13.
48. Smith, D.E., Kaye, A.D., Kang, B., Feng, C.J., DeWitt, B.J., Kadowitz, P.J., and Nossaman, B.D. 1996. Influence of HOE 140, a bradykinin receptor antagonist, in the isolated mesenteric vascular bed of the rat. Am. J. Ther. 3: 479-483.
49. Stegbauer, J., Vonend, O., Oberhauser, V., and Rump, L.C. 2003. Effects of angiotensin-(1-7) and other bioactive components of the renin-angiotensin system on vascular resistance and noradrenaline release in rat kidney. J. Hypertens. 21: 1391-1399. doi:10.1097/00004872-200307000-00030.
50. Tallant, E.A., Lu, X., Weiss, R.B., Chappell, M.C., and Ferrario, C.M. 1997. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension, 29: 388-393.
51. Tom, B., de Vries, R., Saxena, P.R., and Danser, A.H.J. 2001. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N- domain blockade. Hypertension, 38: 95-99.
52. Turner, A.J., and Hooper, N.M. 2002. The angiotensin-converting enzyme gene family: genomics and pharmacology. Trends Pharmacol. Sci. 23: 177-183. doi:10.1016/S0165-6147(00)01994-5.
53. Ueda, S., Masumori-Maemoto, S., Wada, A., Ishii, M., Brosnihan, K.B., and Umemura, S. 2001. Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man. J. Hypertens. 19: 2001-2009. doi:10.1097/00004872- 200111000-00010.
54. Vallon, V., Heyne, N., Richter, K., Khosla, M.C., and Fechter, K. 1998. [7-D-ALA]-angiotensin 1-7 blocks renal actions of angiotensin 1-7 in the anesthetized rat. J. Cardiovasc. Pharmacol. 32: 164-167. doi:10.1097/00005344-199807000-00025.
55. Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., Acton, S., Patane, M., Nichols, A., and Tummino, P. 2002. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 26: 277(17): 14838-14843.
56. Wiemer, G., Schölkens, B.A., Becker, R.H.A., and Busse, R. 1991. Ramiprilat enhances endothelial autocoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension, 18: 558-563.